Share

August 27, 2013; 81 (9) Article

Triple dissociation of attention networks in stroke according to lesion location

Paul Rinne, Mursyida Hassan, Despina Goniotakis, Kiran Chohan, Pankaj Sharma, Dawn Langdon, David Soto, Paul Bentley
First published July 31, 2013, DOI: https://doi.org/10.1212/WNL.0b013e3182a2ca34
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
537

Share

Article Information

vol. 81 no. 9 812-820
DOI: 
https://doi.org/10.1212/WNL.0b013e3182a2ca34
PubMed: 
23902704
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received October 3, 2012
  • Accepted in final form April 22, 2013
  • First Published July 31, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Paul Rinne, MSc,
    2. Mursyida Hassan, MSc,
    3. Despina Goniotakis, MSc,
    4. Kiran Chohan, DPhil,
    5. Pankaj Sharma, MD, FRCP, PhD,
    6. Dawn Langdon, PhD,
    7. David Soto, PhD and
    8. Paul Bentley, MRCP, PhD
  1. Paul Rinne, MSc,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Mursyida Hassan, MSc,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Non - commercial entity. Lecturer (temporary post at UKM , Malaysia)

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Despina Goniotakis, MSc,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Kiran Chohan, DPhil,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Pankaj Sharma, MD, FRCP, PhD,
    6. Scientific Advisory Boards:

    1. Bohringer 2009 advisory board member

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Sanofi/BMS 2008-9 & Bayer 2012 Invited lectures on stroke

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Dawn Langdon, PhD,
    7. Scientific Advisory Boards:

    1. (1) Roche; (2) Merck-Serono; (3) Bayer; (4) Novartis; (5) Vertex

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Presenting at scientific conferences: (1) Bayer, (2) Novartis, (3) Sanofi-Aventis, (4) Serono Symposia

    Editorial Boards:

    1. (1) Multiple Sclerosis and Related Disorders,Psychology and Fatigue Section Editor, 2011-present (2) European Neurological Review, Editorial Board, 2010-present I do not receive any compensation for these journal positions

    Patents:

    1. NONE

    Publishing Royalties:

    1. Verbal and Spatial Reasoning Test, Psychology Press, 1995- present

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Bayer (2) Novartis (Consultancy fees paid into my university charity account)

    Speakers' Bureaus:

    1. (1) Serono; (2) Bayer; (3) Sanofi-Aventis; (4) Novartis; (5) Serono Symposia

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Bayer, research contract to collect cognition data in 21Y LTF study, 2010-11 (2) Bayer, BICAMS sponsorship 2012 (3) Bayer, BICAMS validations

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. (1) RHUL/SGUL, PhD studentship, 2006-9

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. David Soto, PhD and
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Medical Research Council (UK, 89631, www.mrc.ac.uk).

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Paul Bentley, MRCP, PhD
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Division of Brain Sciences (P.R., M.H., D.G., P.S., D.S., P.B.), Imperial College London, Charing Cross Hospital Campus, London; and the Department of Psychology (K.C., D.L.), Royal Holloway University of London, Egham, Surrey, UK.
  1. Correspondence to Dr. Bentley: p.bentley{at}imperial.ac.uk
View Full Text

Article usage

Article usage: July 2013 to April 2023

AbstractFullPdfSource
Jul 20133201Highwire
Aug 201315814384Highwire
Sep 2013707731Highwire
Oct 2013246915Highwire
Nov 201313476Highwire
Dec 201310056Highwire
Jan 20147973Highwire
Feb 20147662Highwire
Mar 20148524Highwire
Apr 20147712Highwire
May 20145846Highwire
Jun 20145083Highwire
Jul 20145159Highwire
Aug 20141900Highwire
Sep 20143100Highwire
Oct 20142532Highwire
Nov 20143338Highwire
Dec 20142621Highwire
Jan 20153530Highwire
Jan 2015062pmc
Feb 20152611Highwire
Feb 20150219pmc
Mar 20154421Highwire
Mar 20150169pmc
Apr 20153810Highwire
Apr 2015083pmc
May 20151734Highwire
May 20150152pmc
Jun 20153813Highwire
Jun 2015076pmc
Jul 20152401Highwire
Jul 20150148pmc
Aug 20153841Highwire
Aug 20150124pmc
Sep 20152111Highwire
Sep 2015071pmc
Oct 20151701Highwire
Oct 2015061pmc
Nov 20152402Highwire
Nov 201501815pmc
Dec 20152101Highwire
Dec 20150166pmc
Jan 20162611Highwire
Jan 20160910pmc
Feb 20161611Highwire
Feb 2016054pmc
Mar 20162300Highwire
Mar 20160214pmc
Apr 20162843Highwire
Apr 2016074pmc
May 20162724Highwire
May 201602410pmc
Jun 20162600Highwire
Jun 20160109pmc
Jul 20162500Highwire
Jul 20160135pmc
Aug 20162700Highwire
Aug 2016052pmc
Sep 20164500Highwire
Sep 20160112pmc
Oct 20162600Highwire
Oct 20160154pmc
Nov 20163000Highwire
Nov 20160188pmc
Dec 20162914Highwire
Dec 20160138pmc
Jan 20173200Highwire
Jan 2017093pmc
Feb 20173400Highwire
Feb 2017095pmc
Mar 20172404Highwire
Mar 20170188pmc
Apr 20171911Highwire
Apr 201711113pmc
May 20171200Highwire
May 2017599pmc
Jun 20171100Highwire
Jun 2017389pmc
Jul 2017600Highwire
Jul 2017288pmc
Aug 20171400Highwire
Aug 201711112pmc
Sep 20171000Highwire
Sep 20177118pmc
Oct 20171001Highwire
Oct 2017288pmc
Nov 20171201Highwire
Nov 201792826pmc
Dec 2017700Highwire
Jan 2018800Highwire
Feb 20183023Highwire
Mar 2018922Highwire
Apr 20182012Highwire
Apr 201811114pmc
May 20185121Highwire
Jun 20181701Highwire
Jun 2018587pmc
Jul 20183324Highwire
Aug 20183301Highwire
Aug 2018399pmc
Sep 20181200Highwire
Oct 20181922Highwire
Nov 20185900Highwire
Dec 20181500Highwire
Jan 20191501Highwire
Feb 20192331Highwire
Mar 20192000Highwire
Apr 20192401Highwire
May 20193002Highwire
Jun 20192701Highwire
Jul 20192201Highwire
Aug 20191900Highwire
Sep 20192700Highwire
Oct 20194022Highwire
Nov 20193521Highwire
Dec 20192611Highwire
Jan 20204101Highwire
Feb 20203600Highwire
Mar 20204211Highwire
Apr 20202722Highwire
May 20203500Highwire
Jun 20204000Highwire
Jul 20204401Highwire
Aug 20203300Highwire
Sep 20204111Highwire
Oct 20202010Highwire
Nov 20203010Highwire
Dec 20203700Highwire
Jan 20213500Highwire
Feb 20214430Highwire
Mar 20213300Highwire
Apr 20213722Highwire
May 20213000Highwire
Jun 20212400Highwire
Jul 20215200Highwire
Aug 20213210Highwire
Sep 20213700Highwire
Oct 20214613Highwire
Nov 20214831Highwire
Dec 20213600Highwire
Jan 20225500Highwire
Feb 20224910Highwire
Mar 20222800Highwire
Apr 20222910Highwire
May 20222800Highwire
Jun 20221300Highwire
Jul 20222612Highwire
Aug 20222700Highwire
Sep 20222911Highwire
Oct 20226200Highwire
Nov 20224001Highwire
Dec 20223400Highwire
Jan 20232900Highwire
Feb 20231300Highwire
Mar 20234100Highwire
Apr 20232310Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles